Determinants of high residual post-PCV13 pneumococcal vaccine-type carriage in Blantyre, Malawi: a modelling study
<p><strong>Background</strong></p> <p>In November 2011, Malawi introduced the 13-valent pneumococcal conjugate vaccine (PCV13) into the routine infant schedule. Four to 7 years after introduction (2015–2018), rolling prospective nasopharyngeal carriage surveys were perf...
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Published: |
BioMed Central
2019
|
| _version_ | 1826264667410923520 |
|---|---|
| author | Lourenço, J Obolski, U Swarthout, T Gori, A Bar-Zeev, N Everett, D Kamng’Ona, A Mwalukomo, T Mataya, A Mwansambo, C Banda, M Gupta, S French, N Heyderman, R |
| author_facet | Lourenço, J Obolski, U Swarthout, T Gori, A Bar-Zeev, N Everett, D Kamng’Ona, A Mwalukomo, T Mataya, A Mwansambo, C Banda, M Gupta, S French, N Heyderman, R |
| author_sort | Lourenço, J |
| collection | OXFORD |
| description | <p><strong>Background</strong></p> <p>In November 2011, Malawi introduced the 13-valent pneumococcal conjugate vaccine (PCV13) into the routine infant schedule. Four to 7 years after introduction (2015–2018), rolling prospective nasopharyngeal carriage surveys were performed in the city of Blantyre. Carriage of Streptococcus pneumoniae vaccine serotypes (VT) remained higher than reported in high-income countries, and impact was asymmetric across age groups.</p> <p><strong>Methods</strong></p> A dynamic transmission model was fit to survey data using a Bayesian Markov-chain Monte Carlo approach, to obtain insights into the determinants of post-PCV13 age-specific VT carriage. <p><strong>Results</strong></p> <p>Accumulation of naturally acquired immunity with age and age-specific transmission potential were both key to reproducing the observed data. VT carriage reduction peaked sequentially over time, earlier in younger and later in older age groups. Estimated vaccine efficacy (protection against carriage) was 66.87% (95% CI 50.49–82.26%), similar to previous estimates. Ten-year projected vaccine impact (VT carriage reduction) among 0–9 years old was lower than observed in other settings, at 76.23% (CI 95% 68.02–81.96%), with sensitivity analyses demonstrating this to be mainly driven by a high local force of infection.</p> <p><strong>Conclusions</strong></p> <p>There are both vaccine-related and host-related determinants of post-PCV13 pneumococcal VT transmission in Blantyre with vaccine impact determined by an age-specific, local force of infection. These findings are likely to be generalisable to other Sub-Saharan African countries in which PCV impact on carriage (and therefore herd protection) has been lower than desired, and have implications for the interpretation of post-PCV carriage studies and future vaccination programs.</p> |
| first_indexed | 2024-03-06T20:11:31Z |
| format | Journal article |
| id | oxford-uuid:2ab8cf30-65c7-4486-8d36-5ac230fb32f9 |
| institution | University of Oxford |
| last_indexed | 2024-03-06T20:11:31Z |
| publishDate | 2019 |
| publisher | BioMed Central |
| record_format | dspace |
| spelling | oxford-uuid:2ab8cf30-65c7-4486-8d36-5ac230fb32f92022-03-26T12:26:44ZDeterminants of high residual post-PCV13 pneumococcal vaccine-type carriage in Blantyre, Malawi: a modelling studyJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:2ab8cf30-65c7-4486-8d36-5ac230fb32f9Symplectic Elements at OxfordBioMed Central2019Lourenço, JObolski, USwarthout, TGori, ABar-Zeev, NEverett, DKamng’Ona, AMwalukomo, TMataya, AMwansambo, CBanda, MGupta, SFrench, NHeyderman, R<p><strong>Background</strong></p> <p>In November 2011, Malawi introduced the 13-valent pneumococcal conjugate vaccine (PCV13) into the routine infant schedule. Four to 7 years after introduction (2015–2018), rolling prospective nasopharyngeal carriage surveys were performed in the city of Blantyre. Carriage of Streptococcus pneumoniae vaccine serotypes (VT) remained higher than reported in high-income countries, and impact was asymmetric across age groups.</p> <p><strong>Methods</strong></p> A dynamic transmission model was fit to survey data using a Bayesian Markov-chain Monte Carlo approach, to obtain insights into the determinants of post-PCV13 age-specific VT carriage. <p><strong>Results</strong></p> <p>Accumulation of naturally acquired immunity with age and age-specific transmission potential were both key to reproducing the observed data. VT carriage reduction peaked sequentially over time, earlier in younger and later in older age groups. Estimated vaccine efficacy (protection against carriage) was 66.87% (95% CI 50.49–82.26%), similar to previous estimates. Ten-year projected vaccine impact (VT carriage reduction) among 0–9 years old was lower than observed in other settings, at 76.23% (CI 95% 68.02–81.96%), with sensitivity analyses demonstrating this to be mainly driven by a high local force of infection.</p> <p><strong>Conclusions</strong></p> <p>There are both vaccine-related and host-related determinants of post-PCV13 pneumococcal VT transmission in Blantyre with vaccine impact determined by an age-specific, local force of infection. These findings are likely to be generalisable to other Sub-Saharan African countries in which PCV impact on carriage (and therefore herd protection) has been lower than desired, and have implications for the interpretation of post-PCV carriage studies and future vaccination programs.</p> |
| spellingShingle | Lourenço, J Obolski, U Swarthout, T Gori, A Bar-Zeev, N Everett, D Kamng’Ona, A Mwalukomo, T Mataya, A Mwansambo, C Banda, M Gupta, S French, N Heyderman, R Determinants of high residual post-PCV13 pneumococcal vaccine-type carriage in Blantyre, Malawi: a modelling study |
| title | Determinants of high residual post-PCV13 pneumococcal vaccine-type carriage in Blantyre, Malawi: a modelling study |
| title_full | Determinants of high residual post-PCV13 pneumococcal vaccine-type carriage in Blantyre, Malawi: a modelling study |
| title_fullStr | Determinants of high residual post-PCV13 pneumococcal vaccine-type carriage in Blantyre, Malawi: a modelling study |
| title_full_unstemmed | Determinants of high residual post-PCV13 pneumococcal vaccine-type carriage in Blantyre, Malawi: a modelling study |
| title_short | Determinants of high residual post-PCV13 pneumococcal vaccine-type carriage in Blantyre, Malawi: a modelling study |
| title_sort | determinants of high residual post pcv13 pneumococcal vaccine type carriage in blantyre malawi a modelling study |
| work_keys_str_mv | AT lourencoj determinantsofhighresidualpostpcv13pneumococcalvaccinetypecarriageinblantyremalawiamodellingstudy AT obolskiu determinantsofhighresidualpostpcv13pneumococcalvaccinetypecarriageinblantyremalawiamodellingstudy AT swarthoutt determinantsofhighresidualpostpcv13pneumococcalvaccinetypecarriageinblantyremalawiamodellingstudy AT goria determinantsofhighresidualpostpcv13pneumococcalvaccinetypecarriageinblantyremalawiamodellingstudy AT barzeevn determinantsofhighresidualpostpcv13pneumococcalvaccinetypecarriageinblantyremalawiamodellingstudy AT everettd determinantsofhighresidualpostpcv13pneumococcalvaccinetypecarriageinblantyremalawiamodellingstudy AT kamngonaa determinantsofhighresidualpostpcv13pneumococcalvaccinetypecarriageinblantyremalawiamodellingstudy AT mwalukomot determinantsofhighresidualpostpcv13pneumococcalvaccinetypecarriageinblantyremalawiamodellingstudy AT matayaa determinantsofhighresidualpostpcv13pneumococcalvaccinetypecarriageinblantyremalawiamodellingstudy AT mwansamboc determinantsofhighresidualpostpcv13pneumococcalvaccinetypecarriageinblantyremalawiamodellingstudy AT bandam determinantsofhighresidualpostpcv13pneumococcalvaccinetypecarriageinblantyremalawiamodellingstudy AT guptas determinantsofhighresidualpostpcv13pneumococcalvaccinetypecarriageinblantyremalawiamodellingstudy AT frenchn determinantsofhighresidualpostpcv13pneumococcalvaccinetypecarriageinblantyremalawiamodellingstudy AT heydermanr determinantsofhighresidualpostpcv13pneumococcalvaccinetypecarriageinblantyremalawiamodellingstudy |